ARTICLE | Company News
Alfacell other research news
February 20, 2001 8:00 AM UTC
Under a CRADA with the National Cancer Institute, the parties will link single-chain antibody gene sequences to Onconase for use in developing therapeutics that selectively target a variety of tumor t...